3. Results
thrombosis, no-reflow, coronary perforations, contrast-induced nephropathy
THROMBOSIS, MYOCARDIAL INFARCTION (MI), CARDIAC DEATH, VASCULAR ACCESS SITE COMPLICATION, CONTRAST-INDUCED NEPHROPATHY
Of patients included in the trial, seven (41.2%) were female, and 10 (58.8%) were male, with a median age of 64 years and median body mass index of 28.5 ± 4.6 kg/mDuring acute hospitalization, there were no statistically significant differences in the amount and length of stents implanted, the length of hospital stay, and the number of PCI-related MACEs between groups. Index PCI duration was significantly longer, and the volume of contrast media delivered was significantly greater in the iFR-guided group than in the angiography-guided group (119.4 ± 40.7 vs. 47.0 ± 15.5 min, Though when complete myocardial revascularization was achieved, in both groups (results collected at the 3-month follow-up) there were no significant differences in: the amount and length of stents implanted; the total volume of contrast media delivered; total PCI duration; the length of overall hospital stay; and total PCI-related MACEs (comprising of cardiac death, non-fatal myocardial infarction (MI), unplanned revascularization, stent thrombosis, flow limiting coronary dissections, no-reflow phenomenon, coronary perforations, coronary distal embolization, vascular access site complications requiring blood transfusion or surgical intervention, and contrast-induced nephropathy requiring hospitalization) between groups. The complete simultaneous myocardial revascularization strategy executed in the iFR-guided group required a significantly smaller number of PCI attempts than did the staged approach of the angiography-guided group (1.0 ± 0.0 vs. 1.8 ± 0.7 PCIs, 